Home › Esophageal Adenocarcinoma › Illinois › Springfield
Esophageal Adenocarcinoma clinical trials in Springfield, IL
3 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Springfield (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RecruitingPhase 2/3
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RecruitingPhase 3
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Southern Illinois University - Simmons Cancer Institute, Springfield
- Springfield Clinic Radiology - 800 Building, Springfield
- Springfield Clinic Urgent Care Plus, Springfield
- and 4 more
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Arlington, VA11 studies
- Nashville, TN11 studies
- Durham, NC10 studies
- Baldwin Park, CA9 studies
- Rochester, MN9 studies
- St. Louis, MO9 studies
- Jacksonville, FL9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
Other studies in Springfield
- Non-Small Cell Lung Cancer13 studies
- Lung Cancer12 studies
- Colorectal Cancer9 studies
- Breast Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Cancer (all types)6 studies
- Bladder Cancer6 studies
- Prostate Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Kidney Cancer (Renal Cell Carcinoma)6 studies
- Pancreatic Cancer5 studies
- Melanoma5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.